ISEE - IVERIC bio Q4 2022 Earnings Preview
- IVERIC bio ( NASDAQ: ISEE ) is scheduled to announce Q4 earnings results on Wednesday, March 1st, before markets open.
- The consensus EPS Estimate is -$0.37 (-27.6% Y/Y) and the consensus Revenue Estimate is $0M
- Over the last 3 months, EPS estimates have seen 1 upward revision and 0 downward.
For further details see:
IVERIC bio Q4 2022 Earnings Preview